LeMaitre Vascular, Inc. (LMAT)
NASDAQ: LMAT · Real-Time Price · USD
106.15
-0.26 (-0.24%)
At close: Mar 5, 2026, 4:00 PM EST
108.27
+2.12 (2.00%)
After-hours: Mar 5, 2026, 6:25 PM EST
LeMaitre Vascular Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for LeMaitre Vascular stock have an average target of 105.8, with a low estimate of 94 and a high estimate of 118. The average target predicts a decrease of -0.33% from the current stock price of 106.15.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for LeMaitre Vascular stock from 5 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 3 | 3 | 3 | 2 | 1 |
| Buy | 2 | 1 | 1 | 1 | 2 | 2 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 6 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barrington Research | Barrington Research | Buy Maintains $95 → $105 | Buy | Maintains | $95 → $105 | -1.08% | Feb 26, 2026 |
| Roth Capital | Roth Capital | Strong Buy Reiterates $108 → $117 | Strong Buy | Reiterates | $108 → $117 | +10.22% | Feb 26, 2026 |
| Wells Fargo | Wells Fargo | Hold Maintains $87 → $94 | Hold | Maintains | $87 → $94 | -11.45% | Feb 26, 2026 |
| Citizens | Citizens | Buy Maintains $113 → $118 | Buy | Maintains | $113 → $118 | +11.16% | Feb 26, 2026 |
| Barrington Research | Barrington Research | Buy Maintains $95 | Buy | Maintains | $95 | -10.50% | Feb 20, 2026 |
Financial Forecast
Revenue This Year
283.70M
from 249.60M
Increased by 13.66%
Revenue Next Year
309.15M
from 283.70M
Increased by 8.97%
EPS This Year
2.88
from 2.52
Increased by 14.14%
EPS Next Year
3.17
from 2.88
Increased by 10.09%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 294.5M | 323.5M | |||
| Avg | 283.7M | 309.2M | |||
| Low | 265.1M | 285.2M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 18.0% | 14.0% | |||
| Avg | 13.7% | 9.0% | |||
| Low | 6.2% | 0.5% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 3.07 | 3.40 | ||
| Avg | 2.88 | 3.17 | ||
| Low | 2.43 | 2.61 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 21.7% | 18.3% | ||
| Avg | 14.1% | 10.1% | ||
| Low | -3.6% | -9.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.